Medical treatments and practices. What should be done when a prostaglandin proves ineffective?

被引:0
作者
Nordmann, JP [1 ]
机构
[1] Hop Quinze Vingts, Ctr Glaucome, F-75012 Paris, France
来源
JOURNAL FRANCAIS D OPHTALMOLOGIE | 2005年 / 28卷
关键词
glaucoma; prostaglandin analogs; intraocular pressure; therapeutic efficacy; side effects; therapy;
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Prostaglandin analogs are very frequently used as first-line therapy in the treatment of glaucoma. In some cases, they may be ineffective or insufficient or they may induce side effects. The absence of an ocular pressure-lowering effect of a prostaglandin is in general a class effect. Thus a switch to another prostaglandin will probably not be more effective. In such cases, it may be better to use another therapeutic class. On the other hand, the side effects of prostaglandin are more often directly related to the chemical structure of the drug used and may not occur with another prostaglandin. Consequently, considering the dramatic effect of prostaglandin on ocular pressure compared to other drugs, when one prostaglandin causes side effects, it may be useful to try another one before changing the drug family.
引用
收藏
页码:S41 / S44
页数:4
相关论文
共 10 条
[1]   Bimatoprost and travoprost: A review of recent studies of two new glaucoma drugs [J].
Eisenberg, DL ;
Toris, CB ;
Camras, CB .
SURVEY OF OPHTHALMOLOGY, 2002, 47 :S105-S115
[2]   Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension [J].
Gandolfi, S ;
Simmons, ST ;
Sturm, R ;
Chen, KK ;
Vandenburgh, AM .
ADVANCES IN THERAPY, 2001, 18 (03) :110-121
[3]   A comparison of the effects on intraocular pressure of latanoprost 0.005% and the fixed combination of dorzolamide 2% and timolol 0.5% in patients with open-angle glaucoma [J].
Honrubia, FM ;
Larsson, LI ;
Spiegel, D .
ACTA OPHTHALMOLOGICA SCANDINAVICA, 2002, 80 (06) :635-641
[4]   Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension [J].
Netland, PA ;
Landry, T ;
Sullivan, EK ;
Andrew, R ;
Silver, L ;
Weiner, A ;
Mallick, S ;
Dickerson, J ;
Bergamini, MVW ;
Robertson, SM ;
Davis, AA .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2001, 132 (04) :472-484
[5]   A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma [J].
Noecker, RS ;
Dirks, MS ;
Choplin, NT ;
Bernstein, P ;
Batoosingh, AL ;
Whitcup, SM .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 135 (01) :55-63
[6]   A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data [J].
Nordmann, JP ;
Mertz, B ;
Yannoulis, NC ;
Schwenninger, C ;
Kapik, B ;
Shams, N .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2002, 133 (01) :1-10
[7]  
Orzalesi N, 2000, INVEST OPHTH VIS SCI, V41, P2566
[8]   A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: A 12-week, randomized, masked-evaluator multicenter study [J].
Parrish, RK ;
Palmberg, P ;
Sheu, WP .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 135 (05) :688-703
[9]   Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure [J].
Sherwood, M ;
Brandt, J .
SURVEY OF OPHTHALMOLOGY, 2001, 45 :S361-S368
[10]   A six-month, randomized, double masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension [J].
Watson, P ;
Stjernschantz, J ;
Beck, L ;
Blackmore, M ;
Coakes, R ;
Reynolds, P ;
Davey, C ;
HickmanCasey, J ;
Elkington, A ;
Luff, A ;
Green, F ;
Valenzuela, F ;
Longstaff, S ;
Currie, Z ;
Mills, B ;
Chatterjee, A ;
Murray, S ;
Nagasubramanian, S ;
Potts, M ;
Spencer, I ;
Roxburgh, S ;
Sanders, R ;
Bailey, M ;
Vernon, S ;
Sloper, M ;
Wishart, P ;
Birch, M .
OPHTHALMOLOGY, 1996, 103 (01) :126-137